SLCO1B1型
单倍型
等位基因
药物遗传学
命名法
遗传学
1000基因组计划
基因
计算生物学
生物
单核苷酸多态性
基因型
分类学(生物学)
植物
作者
Laura B. Ramsey,Li Gong,Seung‐been Lee,Jon Wagner,Xujia Zhou,Katrin Sangkuhl,Solomon M. Adams,Robert J. Straka,Philip E. Empey,Erin C. Boone,Teri E. Klein,Mikko Niemi,Andrea Gaedigk
摘要
The Pharmacogene Variation Consortium (PharmVar) is now providing star (*) allele nomenclature for the highly polymorphic human SLCO1B1 gene encoding the organic anion transporting polypeptide 1B1 (OATP1B1) drug transporter. Genetic variation within the SLCO1B1 gene locus impacts drug transport, which can lead to altered pharmacokinetic profiles of several commonly prescribed drugs. Variable OATP1B1 function is of particular importance regarding hepatic uptake of statins and the risk of statin‐associated musculoskeletal symptoms. To introduce this important drug transporter gene into the PharmVar database and serve as a unified reference of haplotype variation moving forward, an international group of gene experts has performed an extensive review of all published SLCO1B1 star alleles. Previously published star alleles were self‐assigned by authors and only loosely followed the star nomenclature system that was first developed for cytochrome P450 genes. This nomenclature system has been standardized by PharmVar and is now applied to other important pharmacogenes such as SLCO1B1 . In addition, data from the 1000 Genomes Project and investigator‐submitted data were utilized to confirm existing haplotypes, fill knowledge gaps, and/or define novel star alleles. The PharmVar‐developed SLCO1B1 nomenclature has been incorporated by the Clinical Pharmacogenetics Implementation Consortium (CPIC) 2022 guideline on statin‐associated musculoskeletal symptoms.
科研通智能强力驱动
Strongly Powered by AbleSci AI